Pharmaceutial & Healthcare

 The global anastomosis devices market was valued at 15.74 Million in 2016 and is expected to continue growing at a higher rate. Factors such as rise in surgical procedures with rising incidences of cardiovascular and GT diseases are likely to contribute to the market growth in the forecast period. Overall, the anastomosis devices market is expected to cross a CAGR of 5.2% in the forecast period. Surgical procedures have now turned into a perplexed form for cardiac surgeons right from the inception of coronary arteries bypass grafts and minimally invasive techniques. Suture technique for coronary anastomosis is becoming insufficient to suffice new demands from surgeons hence a need arises for alternative techniques to perform coronary bypasses. Due to the recent medical advancements, sutureless devices are based on memory shape metal alloy, synthetic, and biologic glue combined or non-combined with metallic framework and laser bonding using organic soldering techniques. Anastomosis dev

Global Allantoin Market estimated to stretch till US$ 641.7 million by the year 2022. Growing demand for the product, required for the production of precautionary healthcare merchandises, due to its possessions such as soothing, anti-irritant, and moisturizing, is likely to motivate the progress of the market above the prediction period. The allantoin market is expected to develop by a CAGR of 6.1%. The business is likely to observe greater development in the uses of cosmetics due to its greater demand for the production of bath, hair care, hand care, and face care merchandises. Increasing usage opportunity for the product, in oral care merchandises, for example toothpaste and mouthwashes is likely to take an optimistic influence on the progress of the business above the prediction period. The division of the international market of Allantoin on the source of Type of Application could span Oral Cleanliness, Cosmetic, and Medicinal. The subdivision of Medicinal application is likely to

 The global dental practice management software market has crossed USD 888 million and is anticipated to exhibit a CAGR of 6.8% in the forecast period. Rise in aging population coupled with demand for oral healthcare services is likely to gain a significant market in the forecast period. The other factors such as rise in digitization and healthcare budgets is likely to contribute to the market growth in the forthcoming period. Subsequently, dental practice management software streamlines the work processes of dental practices to enhance efficiency and patient care. Medical care services are now adopting online services in order to create optimized benefits for stakeholders and investors and out of this objective, the dental practice management software resolves all the data related problems arising out of dental diagnosis. On the other hand, the traditional methods such as manual form filling and filing enable the customers to fill their registration form in detail for further filing.

 The global hospital information systems (HIS) market is expected to be valued at USD 39.7 billion by 2025. Hospital information system market demand is expected to be high over the forecast period on account of increasing patient traffic. The need to integrate data of a single patient from all the departments in a hospital is anticipated to propel the overall industry growth.  Hospital information system (HIS) is designed to fulfill the administrational needs of medical centers. It involves the integration of multiple divisions in order to manage the administration on a real time basis. Various sections of a medical center which include laboratories, finance departments, and general administration are integrated through enterprise architecture. It also helps the physicians in tracking a patients’ past record and progress in the treatment. The increase in patient flow is the major factor driving the overall market. Increasing disease incidence has created the need to establish a sophis

 The global Pneumatic Conveying Systems Market subject to witness a substantial growth due to the growing adoption of advanced manufacturing methods and development of application specific and tailor-made products. The recent technological advancement in the manufacturing sector coupled with application specific automated devices to improve productivity in various end-user industry is expected to drive the growth of pneumatic conveying systems industry over the next seven years. Development of compact pressure-vessel conveying systems with intelligent control technology is expected to boost market demand over the next seven years. Use of pneumatic conveying systems helps to increase productivity and limits operation downtime, thereby propelling market growth. Pneumatic conveying systems also helps to enhance quality of end-product. Globally, the pneumatic conveying system market is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market play

 Global transdermal drug delivery system market is anticipated to reach USD 81.4 billion by 2024 owing to shift toward sedentary lifestyle that encourages chronic disorders. Transdermal drug delivery is a painless process of delivering drug in the body part. TDDS delivers drug through the skin in pre-decided and regulated rate. It offers extended therapeutic effects, lesser side-effects, improved patient compliance, better bioavailability, and easy cessation of drug treatment. Transdermal drug delivery is much preferred today as compared to the conventional oral method or injectables. Transdermal drug delivery systems market is witnessing growth due to the factors like increasing consumer preference for minimally invasive procedures for chronic disorders and multiple advantages associated with TDDS. Infusion of drug could be effectively monitored and projected creditably through transdermal drug delivery method, which makes it convenient to maintain steady level of drug. However, trans

 The global preimplantation genetic testing (PGD/PGT) market is expected to value at USD 221.1 million by 2024. The market is subject to witness a substantial growth due to the rising awareness in regards to genetic techniques and increasing adoption for detection of chromosomal abnormalities. Use of preimplantation genetic testing (PGD/PGS) for embryo screening to perform in vitro fertilization (IVF) is expected to boost market growth over the forecast period. Identification of genetic disorders and inherited conditions with the help of preimplantation genetic testing (PGT) and diagnosis is predicted to foster market growth over the upcoming years. Globally, the preimplantation genetic testing industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the preimplantation genetic testing market. Early diagnosis of the chromosomal disorders helps to reduce the number of people sufferi

 The global polycystic ovarian syndrome (PCOS) treatment market size is expected to value at USD 5.1 billion by 2025. The market is subject to witness a substantial growth due to the easy identification of symptoms associated with this syndrome, and easy accessibility to a range of drug essential for the treatment. Furthermore, substantial focus on the development of the drug to find permeant solution involving complete cure for the polycystic ovarian syndrome (PCOS) and rising investment by industry players for research development of drugs are some of the critical factors expected to fuel growth of the PCOS treatment market during the forecast period. Globally, the market is predicted to grow at CAGR of 5.0% in forecast period, providing numerous opportunity for market players to invest for research and development in the polycystic ovarian syndrome (PCOS) treatment market. Currently, no particular medication has been developed for treatment of PCOS treatment market. Thus, symptoms d

 The global Xerostomia (Dry Mouth) Therapeutics Market is anticipated to reach USD 796.1 million and is anticipated to grow at a CAGR of 3.2% in the years to come. Xerostomia is a clinical condition of dry mouth and does not show the signs of hyposalivation and symptoms on frequent terms. This condition is observed when the rate of saliva flow is low in comparison with absorption across the oral mucosa coupled with rate of fluid evaporation from the mouth. Prolonged xerostomia is a significant disease in patients since it affects speech, chewing, denture-wearing, and swallowing activities. The defined causes of hyposalivation and xerostomia are the use of several medications such as antidepressants, anticoagulants, antiretroviral, hypoglycemics, multivitamins and supplements, and anti-inflammatory drugs. Prevalence of xerostomia persists in a large population with different age groups despite following medical or dental consultation. Rise in use of prescribed medication coupled with ri

 The global Hemoglobinopathies Market size is expected to value at USD 8.82 billion by 2022. The hemoglobinopathies industry is subject to witness a substantial growth due to the growing prevalence of hemoglobinopathies, particularly in underdeveloped economies such as South East Asia, Middle East region, and Africa. In addition, increasing number of high unmet needs for diagnosis and treatment of these disorders is expected to fuel the growth of hemoglobinopathies market over the next seven years. Globally, the hemoglobinopathies industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the market. Hemoglobinopathy is commonly known as a genetic defect, which results in abnormal structure of single globin chains of the hemoglobin molecule. Hemoglobinopathies are hereditary or inherited single gene disorders. The hemoglobinopathies are also referred as autosomal co-dominant traits d

 The global Botulinum Toxin Market size is expected to value at USD 7.3 billion by 2025. The market is subject to witness a substantial growth due to the ever-growing population and rising number of minimally invasive or non-invasive procedures performed each year. Botulinum toxin is commonly used as a neurotoxin, which is typically found in various antigenic forms namely BNT-A, BNT-B, BTT-C, BNT-D, BNT-E, BNT-F and BNT-G. These antigenic forms are produced with the help of an anaerobic bacterium, Clostridium botulinum. Common application of the botulinum toxin is the aesthetic therapy. Hence, these factors are expected to play vital for sustained market growth in the upcoming years. Globally, the botulinum toxin industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the market of botulinum toxin. However, use of botulinum toxin has severe side effects such as allergic reactions,

 The global Cartilage Repair/Regeneration Market size is expected to value at USD 6.7 billion by 2025. The market is subject to witness a substantial growth due to the increasing occurrence of bone and joint related diseases such as Osteoarthritis (OA) and arthritis, and recent technological advancements in cartilage regeneration. Growing geriatric population in across the globe, is susceptible towards Osteoarthritis (OA) and arthritis due to weakened bone structure. This in return is expected to fuel the growth of cartilage repair/regeneration industry over the forecast period. Additionally, change in food patterns leading to obesity is considered as one of the prominent factor associated with market growth, in the recent years. Globally, the cartilage repair/regeneration market is predicted to grow at CAGR of 5.4% in forecast period, providing numerous opportunities for market players to invest in research and development in the market. Growing prevalence of diabetes is considered as

 The global Joint Reconstruction Devices Market size is expected to value at USD 30.4 billion by 2025. The market is subject to witness a substantial growth due to the increasing adoption of minimally invasive surgeries and recent technological advancement in the healthcare sector. Factors such as modernization of surgical devices and procedures coupled with increase in the health expenditure by local governments from developed economies across the globe are expected to amplify the growth of the market, in recent years. Globally, the joint reconstruction devices market is predicted to grow at CAGR of 4.9% in forecast period, providing numerous opportunities for market players to invest in research and development in the market. Additionally, the rise in demand for minimally invasive diagnostic, innovative surgical methodologies, increase in occurrence of orthopedic conditions, and a large patient pool are some of the critical factors attributing to the growth of joint reconstruction de

 Global Live Cell Imaging Market is estimated to reach USD 9.0 billion by 2025 owing to the increasing popularity of kinetic research over fixed cellular analysis. Live cell imaging is the study of cells in real-time with the help of images obtained from microscopes and screening systems. Technology has enhanced the approach of scientists to examine proteins, internal cell structures molecular synergy and cellular processes. This allows them to observe cells and to understand the in-depth analysis instead of learning the images of fixed cells. More information that is precise can be achieved with the help of live cell imaging that plays an important role in understanding cell dynamics in research fields like immunology, microbiology, neurology and others. Technological modernizations in live cell imaging are projected to fulfill the demands of different end-users. Technological improvements along with other factors are likely to boost the live cell imaging market in the forecast period

 The global ophthalmic therapeutics/drugs market size is expected to value at USD 35.7 billion by 2025. The market is subject to witness a substantial growth due to the rising occurrence of eye diseases like presbyopia, macular degeneration, and retinal vascular disease, particularly in geriatric population. Increasing focus on research and development in ophthalmic therapeutics and drugs by private bodies due to rising occurrence of ocular disorders, are driving factors for growth of the market. Globally, the ophthalmic therapeutics/drugs industry is predicted to grow at CAGR of 5.1% in forecast period, providing numerous opportunity for market players to invest for research and development in the market. Cataract is the one of the primary cause of blindness. Other types of disorders such as retinal vascular disease, glaucoma, and age-associated macular degeneration can also lead to blindness. Thus, rise in the number of initiatives and programs taken by governmental agencies in order